Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05951075 · ClinicalTrials.gov registry record · NA

Prospective Study on Power Prenatal Vitamins for Males on YO Score At-home Sperm Test Results

A NA study of Infertility, Male and Spermatogenesis and Semen Disorders, sponsored by The Bird and Be Co.

Recruiting
Registry status
NA
Development phase
174
Enrollment target
1
Study location

NCT05951075: Recruiting NA study of Infertility, Male and Spermatogenesis and Semen Disorders, sponsored by The Bird and Be Co.

NCT05951075 is a NA study of Infertility, Male and Spermatogenesis and Semen Disorders that is actively recruiting participants, run by The Bird and Be Co. The registered enrollment target is 174 participants, below the 556-participant average among 8 other Infertility, Male trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05951075, a NA study of Infertility, Male and Spermatogenesis and Semen Disorders, is actively recruiting participants, sponsored by The Bird and Be Co.

RECRUITING
Registry status
NA
Development phase
174 participants
Enrollment target
1
Study location

Study Summary

Male factor infertility is a leading cause of primary and secondary infertility. Poor sperm quality is defined as having an abnormal semen analysis. There are now options to assess sperm quality with at-home sperm analysis kits, including an FDA approved Yo Sperm kit (https://yospermtest.com/) which analyzes the motile sperm concentration \[concentration (millions / ml) x motility (Percentage motile)\] and sperm quality (YO Score) which compares your results to laboratory standards and to other men who have fathered children. The effects of supplements (vitamins, minerals, and anti-oxidants) on improving sperm quality are still debated. Taking additional supplements to improve sperm quality represent a modifiable risk-factor that would be an easy intervention for patients struggling with male factor infertility. The life cycle of sperm production is estimated at 3 months, so any intervention would require a 3 month course to see its full effect. The investigators hypothesize that a 90 day course of the "Power Prenatal for Sperm", a male fertility supplement by Bird\&Be (https://birdandbe.com/the-power-prenatal-for-sperm) will improve sperm quality (YO Score) after taking the supplements.

Primary Outcome

At-home YO Sperm score (10-90) YO Score is a ranking of a participants motile sperm concentration (MSC) compared to other men who have fathered children. The result is 10 to 90 in intervals of 10. A score of10 represents the lowest score (participant ranks above 10% of fathers), and 90 the highest score (participant ranks above 90% of fathers). The higher your YO Score, the more likely you are to achieve a pregnancy in a shorter amount of time. YO Score is a reliable tool for monitoring MSC chan

Interventions

  • DIETARY_SUPPLEMENT Power Prenatal for Sperm

Study Locations (1)

California

  • Medical Electronic Systems - Encino

Trial Details

FieldValue
Enrollment Target 174 participants
Start Date 2023-11-01
Est. Completion 2026-12-31
Phase NA
The Bird and Be Co

1 total trials

What NCT05951075 shows while recruiting

NCT05951075 is an interventional study that assigns participants to a tested intervention. The registered 174 participants enrollment target is mid-sized for trials with a published cap, below the 556-participant average among 8 other Infertility, Male trials with a reported enrollment target (69% lower).

The record links to 2 conditions, with Infertility, Male appearing as the primary indexed condition, and to 1 intervention - of which Power Prenatal for Sperm is the first listed.

NCT05951075 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT05951075 about?

NCT05951075 is a clinical study titled "Prospective Study on Power Prenatal Vitamins for Males on YO Score At-home Sperm Test Results". Male factor infertility is a leading cause of primary and secondary infertility. Poor sperm quality is defined as having an abnormal semen analysis. There are now options to assess sperm quality with at-home sperm analysis kits, including an FDA approved Yo Sperm kit (https://yospermtest.com/) whic...

What is the current status of trial NCT05951075?

This trial is currently recruiting. It is a NA study. The enrollment target is 174 participants. The study started on 2023-11-01. Estimated completion is 2026-12-31.

What conditions does trial NCT05951075 study?

This clinical trial studies the following conditions: Infertility, Male, Spermatogenesis and Semen Disorders.

What interventions are being tested in trial NCT05951075?

The interventions under investigation include: Power Prenatal for Sperm (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05951075?

This trial is sponsored by The Bird and Be Co, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05951075 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infertility, Male

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05951075's enrollment target sits among peer trials

174 3rd of 8 higher than 6 of 8 other Infertility, Male trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Infertility, Male trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01000259 · 174 participants

    Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer

  • NCT04729114 · 174 participants · Phase 1

    A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer

  • NCT04884035 · 174 participants · Phase 1

    Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma

  • NCT05075980 · 174 participants · Phase 2

    Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05951075, the US trial registry maintained by the National Library of Medicine. NCT05951075 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.